Cambridge Medixine (CamMed)’s vision is to deliver safer, easier, and faster medicines and therapies to the clinic, ultimately reducing the side effects experienced by patients through novel technologies inspired by natural biological phenomena, engineered and produced within the company.

CamMed is a new start-up company that focuses on creating a new RNA technology platform for vaccines and therapeutics.

Their next-generation mRNA technology is aimed at creating more efficient treatments for patients. Their unprecedented approach is going to bring safer treatments faster to those in need.